These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18937716)

  • 21. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry.
    Norda R; Berséus O; Stegmayr B
    Transfus Apher Sci; 2001 Aug; 25(1):33-41. PubMed ID: 11791760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry.
    Witt V; Stegmayr B; Ptak J; Wikström B; Berlin G; Axelsson CG; Griskevicius A; Centoni PE; Liumbruno GM; Molfettini P; Audzijoniene J; Mokvist K; Sojka BN; Norda R; Ramlow W; Blaha M; Evergren M; Tomaz J
    Transfus Apher Sci; 2008 Dec; 39(3):255-60. PubMed ID: 19010084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic apheresis in the Philippines.
    Narciso CT
    Transfus Apher Sci; 2005 Aug; 33(1):3-9. PubMed ID: 15964239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic apheresis in Taiwan.
    Yeh JH; Chiu HC;
    Ther Apher; 2001 Dec; 5(6):513-6. PubMed ID: 11800091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service.
    Johnson KK; Duvall D; Gilcher RO; Smith JW; Forsberg JE; Terrell DR; Vesely SK; George JN
    J Okla State Med Assoc; 2007 Jul; 100(7):273-8. PubMed ID: 17896615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism as a marker of quality of care in trauma.
    Huseynova K; Xiong W; Ray JG; Ahmed N; Nathens AB
    J Am Coll Surg; 2009 Apr; 208(4):547-52, 552.e1. PubMed ID: 19476788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National survey of hemapheresis practice in Turkey (1998).
    Ilhan O; Uskent N; Arslan O; Arat M; Ozkalemkaş F; Oztürk G; Kalayoglu SB; Ozet A; Tombuloglu M; Arpaci F; Ovali E; Anak S
    Transfus Sci; 2000 Jun; 22(3):195-201. PubMed ID: 10831922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The single center registry for therapeutic apheresis in Turkey: 11-year activity.
    Kadikoylu G; Yavasoglu I; Ozkul A; Akyol A; Yukselen V; Guney E; Bolaman Z
    Transfus Apher Sci; 2012 Aug; 47(1):61-5. PubMed ID: 22583545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective.
    Agreda-Vásquez GP; Espinosa-Poblano I; Sánchez-Guerrero SA; Crespo-Solís E; Cabrera-Vásquez S; López-Salmorán J; Barajas J; Peñaloza-Ramírez P; Tirado-Cárdenas N; Velázquez A
    J Clin Apher; 2008; 23(5):163-7. PubMed ID: 18819155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National survey of hemapheresis practice in Hungary 2001-2004.
    Belák M; Jákó J
    Ther Apher Dial; 2007 Feb; 11(1):22-9. PubMed ID: 17309571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura.
    Lewis QF; Lanneau MS; Mathias SD; Terrell DR; Vesely SK; George JN
    Transfusion; 2009 Jan; 49(1):118-24. PubMed ID: 18954401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
    Blum W; Porcu P
    Semin Thromb Hemost; 2007 Jun; 33(4):350-4. PubMed ID: 17525892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura.
    Marn Pernat A; Buturović-Ponikvar J; Kovac J; Knap B; Premru V; Benedik M; Varl J; Skofic N; Gubensek J; Kersnic B; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):318-21. PubMed ID: 19695067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment.
    Alvarez-Larrán A; del Río-Garma J; Pujol M; de la Rubia J; Hernández-Jodra M; Borrell M; González-Porras JR; García-Gala JM; Viejo A; Enríquez L; Arbona C; García-Erce JA; Noblejas AG; Pereira A
    Ann Hematol; 2009 Oct; 88(10):973-8. PubMed ID: 19205654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of apheresis in children.
    Michon B; Moghrabi A; Winikoff R; Barrette S; Bernstein ML; Champagne J; David M; Duval M; Hume HA; Robitaille N; Bélisle A; Champagne MA
    Transfusion; 2007 Oct; 47(10):1837-42. PubMed ID: 17880609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Italian Registry of Pediatric Therapeutic Apheresis: a report on activity during 2005.
    De Silvestro G; Tison T; Vicarioto M; Bagatella P; Stefanutti C; Marson P
    J Clin Apher; 2009; 24(1):1-5. PubMed ID: 19073013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Future and limits of immunohemotherapy. Great possibilities with apheresis].
    Norda R; Lundkvist I; Söderström T
    Lakartidningen; 1995 Jan; 92(3):155-60. PubMed ID: 7837849
    [No Abstract]   [Full Text] [Related]  

  • 39. The Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology.
    Passalacqua S; Staffolani E; Busnach G; Roccatello D; Pasquali S; Cappelli P; Liuzzo G;
    J Clin Apher; 2005 Jul; 20(2):101-6. PubMed ID: 15880354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
    Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
    Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.